LEPRI, GEMMA
 Distribuzione geografica
Continente #
NA - Nord America 2.180
EU - Europa 1.510
AS - Asia 439
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.140
Nazione #
US - Stati Uniti d'America 2.174
RU - Federazione Russa 716
PL - Polonia 236
IT - Italia 178
IE - Irlanda 168
CN - Cina 131
SE - Svezia 115
SG - Singapore 114
HK - Hong Kong 90
IN - India 53
JO - Giordania 31
FI - Finlandia 25
DE - Germania 22
GB - Regno Unito 18
VN - Vietnam 14
CH - Svizzera 10
CI - Costa d'Avorio 8
ES - Italia 7
CA - Canada 6
KR - Corea 4
BE - Belgio 3
FR - Francia 3
UA - Ucraina 3
AT - Austria 2
RO - Romania 2
AU - Australia 1
EU - Europa 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 4.140
Città #
Santa Clara 538
Fairfield 244
Warsaw 232
Dublin 165
Ashburn 155
Chandler 155
Woodbridge 116
Seattle 102
Cambridge 95
Singapore 95
Houston 80
Wilmington 69
Lawrence 60
Altamura 58
Florence 53
Hong Kong 50
Princeton 50
Moscow 45
Beijing 42
Ann Arbor 39
Boston 36
Mumbai 28
Pune 22
Shanghai 18
Buffalo 13
Dong Ket 12
San Diego 12
Boardman 11
Kent 10
Falls Church 9
Norwalk 9
Abidjan 8
Bern 8
Helsinki 8
New York 8
West Jordan 8
Andover 6
Barcelona 6
Guangzhou 6
Medford 6
Shenzhen 5
Düsseldorf 4
Hillsboro 4
London 4
Scandicci 4
Seoul 4
Yubileyny 4
Brussels 3
Castelliri 3
Los Angeles 3
Naples 3
Polska 3
Redwood City 3
Rome 3
Toronto 3
Turin 3
Hamburg 2
Hangzhou 2
Iesi 2
Jacksonville 2
Malmo 2
Milan 2
Munich 2
Novara 2
Phoenix 2
Pinerolo 2
Reggello 2
Rui'an 2
Salerno 2
Sesto Fiorentino 2
Shijiazhuang 2
Washington 2
Wuhan 2
Zhengzhou 2
Acton 1
Arnsberg 1
Augusta 1
Bremen 1
Bucharest 1
Carpi 1
Casalnuovo 1
Cattolica 1
Chennai 1
Chiswick 1
Gunzenhausen 1
Horben 1
Jiaxing 1
Laurel 1
Livorno 1
Ludwigshafen am Rhein 1
Mahé 1
Mascalucia 1
Montreal 1
Napa 1
Napoli 1
North Bergen 1
Paris 1
Redmond 1
Romola 1
Sydney 1
Totale 2.805
Nome #
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 252
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 186
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 151
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 144
AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) 136
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 127
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 118
The safety of iloprost in systemic sclerosis in a real-life experience 115
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 113
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 112
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 111
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 110
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 101
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 99
SAT0505 Severe Vitamin D Deficiency in Patients with Kawasaki Disease: its Possible Role in the Risk to Develop Coronary Artery Damage 95
Effects of rituximab in connective tissue disorders related interstitial lung disease 93
Antioxidant agents help primary Raynaud's phenomenon 91
PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis 91
Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? 87
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 85
Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections 82
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 80
AB0481 Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Onset Systemic Lupus Erythematosus: A Transversal Study 76
Prognostic value of lung ultrasound B-lines in systemic sclerosis 75
Oral lactobacillus species in systemic sclerosis 71
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 71
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 70
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 68
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 68
Stressful life events at the onset and during the evolution of systemic sclerosis 65
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 65
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 61
Early diagnosis of systemic sclerosis, where do we stand today? 60
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 57
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 57
Systemic Sclerosis Association with Malignancy 56
Recent advances steer the future of systemic sclerosis toward precision medicine 56
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 54
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 54
Very early and early diagnosis of systemic sclerosis 52
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 50
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 49
Systemic sclerosis and primary biliary cholangitis: An overlapping entity? 49
One year in review 2021: systemic sclerosis 48
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 48
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 45
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 36
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 35
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis 35
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 35
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 34
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 34
Systemic sclerosis: one year in review 2022 19
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 8
null 2
Totale 4.242
Categoria #
all - tutte 14.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020362 0 0 0 0 50 49 49 51 50 37 67 9
2020/2021471 24 23 54 106 26 37 19 36 40 62 23 21
2021/2022257 9 12 28 6 18 30 2 22 14 13 28 75
2022/2023753 74 180 27 36 46 117 106 40 76 17 21 13
2023/2024398 10 43 52 12 30 70 18 70 4 52 22 15
2024/20251.595 78 254 155 449 659 0 0 0 0 0 0 0
Totale 4.242